Optimal Surgery for Papillary Thyroid Carcinoma

Authors:

Abstract
There has been a long, unresolved debate regarding the operation of choice for well differentiated carcinoma of the thyroid. We therefore analyzed the feasibility, scope, sample size, and length of follow‐up required to determine the optimal operation for papillary thyroid carcinoma. A statistical approach was used to design a randomized prospective trial comparing the endpoints of complications, recurrence, and cause‐specific mortality. A complication comparison trial is prohibitive owing to the large population required—approximately 12,000 randomized patients. A recurrence trial appears feasible based on sample size: approximately 360 to 800 patients with a 6 to 10‐year follow‐up. However, recurrence detection would be severely compromised in the lobectomy arm, and a unilateral lag‐time bias would occur. A cause‐specific mortality trial proves to be the least objectionable, although a large sample size (n= 3100) would be required. Such a trial is critically dependent on the ability to select an appropriate endpoint. A cause‐specific mortality trial proves to be the most objective and statistically valid endpoint.